Re: Welk, , an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use.
作者信息
Enikeev Dmitry, Taratkin Mark, Lavrinenko Nikolai, Panferov Alexander, Singla Nirmish
机构信息
Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia.
Department of Internal Diseases, Sechenov University, Moscow, Russia.
出版信息
Transl Androl Urol. 2020 Oct;9(5):2299-2301. doi: 10.21037/tau-20-884.
Abstract
摘要
相似文献
1
Re: Welk, , an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use.回复：对于接受小型泌尿外科手术的男性患者，开具阿片类药物处方与新的持续性阿片类药物使用风险增加有关。
Transl Androl Urol. 2020 Oct;9(5):2299-2301. doi: 10.21037/tau-20-884.
2
Opioid prescribing after urologic surgery: we are part of the problem and part of the solution-an invited commentary on "an opioid prescription for men undergoing minor urologic surgery is associated with an increased risk of new persistent opioid use".泌尿外科手术后的阿片类药物处方：我们既是问题的一部分，也是解决方案的一部分——对“接受小型泌尿外科手术男性的阿片类药物处方与新的持续性阿片类药物使用风险增加相关”的特邀评论
Transl Androl Urol. 2020 Jun;9(3):997-1000. doi: 10.21037/tau-2020-05.
3
Re: Welk et al.: the augmented nontransected anastomotic urethroplasty for the treatment of bulbar urethral stricture (urology 2012;79:917-921).回复：韦尔克等人：用于治疗球部尿道狭窄的增强型非横断吻合性尿道成形术（《泌尿外科》2012年；79卷：917 - 921页）
Urology. 2012 Oct;80(4):959; author reply 959-60. doi: 10.1016/j.urology.2012.05.041.
4
National Variation in Opioid Prescription Fills and Long-Term Use in Opioid Naïve Patients after Urological Surgery.尿路上皮癌术后阿片类药物处方和长期使用的国家差异：阿片类药物初治患者。
J Urol. 2019 Nov;202(5):1036-1043. doi: 10.1097/JU.0000000000000343. Epub 2019 Oct 9.
5
Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women.美国女性阴道分娩或剖宫产术后新发持续性阿片类药物使用的发生率。
JAMA Netw Open. 2019 Jul 3;2(7):e197863. doi: 10.1001/jamanetworkopen.2019.7863.
6
Validating the Stopping Opioids after Surgery (SOS) score for sustained postoperative prescription opioid use in spine surgical patients.验证术后停止使用阿片类药物（SOS）评分在脊柱手术患者中持续术后处方阿片类药物使用的适用性。
Spine J. 2019 Oct;19(10):1666-1671. doi: 10.1016/j.spinee.2019.05.001. Epub 2019 May 9.
7
New persistent opioid use among older patients following surgery: A Medicare claims analysis.术后老年患者新的持续性阿片类药物使用：一项 Medicare 索赔分析。
Surgery. 2020 Apr;167(4):732-742. doi: 10.1016/j.surg.2019.04.016. Epub 2019 Jul 23.
8
Association of the Use of a Mandatory Prescription Drug Monitoring Program With Prescribing Practices for Patients Undergoing Elective Surgery.强制性处方药物监测计划的使用与择期手术患者的处方实践之间的关联。
JAMA Surg. 2018 Dec 1;153(12):1105-1110. doi: 10.1001/jamasurg.2018.2666.
9
Evaluation of Opioid Prescriptions After Urogynecologic Surgery Within a Large Health Care Organization: How Much Are We Prescribing?大型医疗保健机构中泌尿妇科手术后阿片类药物处方的评估：我们的处方量有多少？
Female Pelvic Med Reconstr Surg. 2019 Mar/Apr;25(2):125-129. doi: 10.1097/SPV.0000000000000657.
10
New Persistent Opioid Use After Aortic and Mitral Valve Surgery in Commercially Insured Patients.商业保险患者主动脉瓣和二尖瓣手术后新的持续性阿片类药物使用。
Ann Thorac Surg. 2020 Sep;110(3):829-835. doi: 10.1016/j.athoracsur.2019.12.031. Epub 2020 Jan 29.
本文引用的文献
1
Effect of a prospective opioid reduction intervention on opioid prescribing and use after radical prostatectomy: results of the Opioid Reduction Intervention for Open, Laparoscopic, and Endoscopic Surgery (ORIOLES) Initiative.前瞻性阿片类药物减量干预对根治性前列腺切除术后阿片类药物处方和使用的影响：开放式、腹腔镜和内镜手术阿片类药物减量干预（ORIOLES）计划的结果。
BJU Int. 2020 Mar;125(3):426-432. doi: 10.1111/bju.14932. Epub 2019 Nov 15.
2
An Opioid Prescription for Men Undergoing Minor Urologic Surgery Is Associated with an Increased Risk of New Persistent Opioid Use.接受小型泌尿科手术的男性开具阿片类药物处方与新的持续性阿片类药物使用风险增加相关。
Eur Urol. 2020 Jan;77(1):68-75. doi: 10.1016/j.eururo.2019.08.031. Epub 2019 Sep 18.
3
Recommendations for Opioid Prescribing after Endourological and Minimally Invasive Urological Surgery: An Expert Panel Consensus.经内镜手术和微创泌尿外科手术后阿片类药物处方推荐：专家小组共识。
J Urol. 2020 Jan;203(1):151-158. doi: 10.1097/JU.0000000000000514. Epub 2019 Aug 29.
4
Are we facing an opioid crisis in Europe?我们欧洲正面临阿片类药物危机吗？
Lancet Public Health. 2019 Oct;4(10):e483-e484. doi: 10.1016/S2468-2667(19)30156-2. Epub 2019 Aug 20.
5
The opioid crisis in Canada: a national perspective.加拿大的阿片类药物危机：国家视角。
Health Promot Chronic Dis Prev Can. 2018 Jun;38(6):224-233. doi: 10.24095/hpcdp.38.6.02.
6
An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next?在美国和加拿大，阿片类药物的使用、滥用、过量使用及过量使用导致的死亡呈流行态势：欧洲会成为下一个吗？
Bone Joint J. 2017 Jul;99-B(7):856-864. doi: 10.1302/0301-620X.99B7.BJJ-2016-1350.R1.
7
A 1980 Letter on the Risk of Opioid Addiction.一封关于阿片类药物成瘾风险的1980年信件。
N Engl J Med. 2017 Jun 1;376(22):2194-2195. doi: 10.1056/NEJMc1700150.
8
Long-term opioid management for chronic noncancer pain.慢性非癌性疼痛的长期阿片类药物管理
Cochrane Database Syst Rev. 2010 Jan 20;2010(1):CD006605. doi: 10.1002/14651858.CD006605.pub2.
9
Predicting long-term response to strong opioids in patients with low back pain: findings from a randomized, controlled trial of transdermal fentanyl and morphine.预测腰痛患者对强效阿片类药物的长期反应：一项关于透皮芬太尼和吗啡的随机对照试验的结果
BMC Med. 2007 Dec 21;5:39. doi: 10.1186/1741-7015-5-39.
10
Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.透皮丁丙诺啡用于慢性疼痛的长期管理：一项针对来自三项短期临床试验患者的多中心、开放标签随访研究。
Clin Ther. 2006 Jun;28(6):943-52. doi: 10.1016/j.clinthera.2006.06.012.
Zotero 插件